TOP STORIES

• BUSINESS Eisai Aims to Turn Leqembi to Black in FY2026 with EU Approval as Tailwind: CEO
  May 16, 2025

• REGULATORY Chuikyo Agrees to Vet Conditional Scheme for Regenerative Medicine as Elevidys Gets Approval
  May 15, 2025

• REGULATORY Eylea’s Price to Be Axed by 19.5%, Jardiance 12.1% in Market Expansion Rule
  May 15, 2025

• REGULATORY Wegovy, Leqvio, Phozevel Braced for Price Cuts after CEA
  May 15, 2025

• REGULATORY Chuikyo Plans Monthly Debates for CEA Reform in FY2026
  May 15, 2025

• REGULATORY Epkinly, Lunsumio to Face Price Cut of 2.7% under CEA Scheme
  May 15, 2025

• REGULATORY Japan’s Parliament Enacts Bill to Amend PMD Act
  May 15, 2025

• REGULATORY LDP Group Proposes Higher Cap on Social Security Budgets, Category-Based Drug Pricing
  May 14, 2025

• ACADEMIA Japan Consortium to Promote Domestic R&D of Cannabis-Derived Meds
  May 14, 2025

• BUSINESS J&J Taps Chris Rieger to Lead Japan Pharma Business
  May 13, 2025

• REGULATORY MHLW Council Deems 11 “Loss” Products as Medically Highly Necessary
  May 12, 2025

• BUSINESS Takeda on Course to Stable Growth as Late-Stage Assets Near Market
  May 9, 2025

• BUSINESS Lilly Japan Scores Double-Digit Growth for 2nd Year as Mounjaro Delivers
  May 9, 2025

• BUSINESS Shionogi to Buy Torii in 160 Billion Yen Deal, JT Pulls Plug on Pharma Biz
  May 8, 2025

• COMMENTARY New Grad Hires for Sales Reps Up after 5 Years of Decrease: FY2025 Survey
  May 8, 2025

• REGULATORY MHLW to Set Up Special Panel for High-Cost Medical Expense Benefit Program
  May 7, 2025

• BUSINESS Kyowa Kirin’s New Skipper Sees Further Growth Overseas, Vows to Cherish People
  May 1, 2025

• BUSINESS Astellas Gears Up for Xtandi Patent Cliff with Next-Gen Assets, Cost Cuts
  April 28, 2025

• BUSINESS Novo Nordisk Logs 3.6% Growth in Japan in 2024, Driven by Semaglutide
  April 28, 2025

• BUSINESS Sanofi Looks to Join Top 3 in Japan Pharma Market by 2030
  April 25, 2025

ページ

• « 先頭
• ‹ Prev
• …
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• …
• Next ›
• 最終 »